Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence and satisfaction study of Loceryl versus Canesten for toenail onychomycosis
2015-001503-31Phase 4Completed
- Sponsor
- Galderma
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amorolfine and bifonazole + urea in onychomycosis and Distal Lateral Subungual Onychomycosis (DLSO) (2 arms), sponsored by Galderma. Primary endpoint: Subject-reported ease of use, adherence, and satisfaction. Started Oct 2015; status: completed.
02
Drugs
amorolfinebifonazole + urea
03
Conditions
onychomycosisDistal Lateral Subungual Onychomycosis (DLSO)
Beyond the preview
Go deeper on 2015-001503-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001503-31.